News
Interest in the anti-parasitic drug ivermectin skyrocketed during the covid-19 pandemic, but evidence for many of its ...
3h
New Scientist on MSNHerpes virus could soon be approved to treat severe skin cancerA cancer-killing virus could soon be approved for use after shrinking tumours in a third of people with late-stage melanoma ...
Lenacapavir offers twice-yearly HIV prevention with near-complete protection in clinical trials. Clinical trials show ...
Here are the key takeaways from the full Times Magazine story about the F.D.A.: The F.D.A.’s regulators have an enormous ...
Several major medical organizations filed a lawsuit against the HHS and Secretary Robert F. Kennedy Jr. on Monday over what ...
Publix has had to manage several recalls involving both meat and non-meat products since the start of the year.
In recalls, best-by or use-by dates are commonly provided. Even if the affected date has passed, be sure to check your ...
Scientists are developing all sorts of potential new treatments to tackle the most difficult cancer cases—including some that ...
Jeneen Interlandi, a domestic correspondent for Opinion and a staff writer at the magazine, writes frequently about public health. For this article, she interviewed dozens of people who have worked ...
The herpes simplex virus type 1 (HSV-1), which affects almost two‑thirds of the world's population and is generally ...
A research team from Virginia Commonwealth University has found that a drug currently in clinical trials for brain disorders ...
The FDA issued its highest-level risk warning for a recent voluntary recall of hundreds of boxes of organic blueberries ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results